CIBC Asset Management
NVAX icon

CIBC Asset Management’s Novavax NVAX Stock Holding History

CIBC Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,113
Closed -$229K – 1411
2022
Q1 		$229K Hold
3,113
– – ﹤0.01% 1262
2021
Q4 		$445K Buy
3,113
+155
+5% +$26.6K ﹤0.01% 875
2021
Q3 		$613K Buy
2,958
+613
+26% +$135K ﹤0.01% 782
2021
Q2 		$498K Hold
2,345
– – ﹤0.01% 810
2021
Q1 		$425K Buy
+2,345
New +$467K ﹤0.01% 836
2019
Q2 		– Sell
-663
Closed -$7K – 1150
2019
Q1 		$7K Hold
663
– – ﹤0.01% 1107
2018
Q4 		$24K Hold
663
– – ﹤0.01% 1042
2018
Q3 		$25K Hold
663
– – ﹤0.01% 1140
2018
Q2 		$18K Buy
+663
New +$22.4K ﹤0.01% 1131

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CIBC Asset Management's NVAX Position: Q2 2022 in Review

CIBC Asset Management sold out of Novavax (NVAX) in Q2 2022, closing a stake of 3,113 shares — an estimated $229K sold.

CIBC Asset Management first reported a position in NVAX in Q2 2018 and held it in 9 quarters. The position peaked at $613K in Q3 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • CIBC Asset Management reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • CIBC Asset Management sold 3,113 Novavax shares in Q2 2022, an estimated $229K.
  • CIBC Asset Management first reported a position in Novavax in Q2 2018 and held it in 9 quarters.
  • CIBC Asset Management's Novavax position peaked at $613K in Q3 2021.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on CIBC Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.